Sai, Satoshi
Toyoda, Masanori http://orcid.org/0000-0002-0152-5699
Tobimatsu, Kazutoshi
Satake, Hironaga
Yasui, Hisateru
Kimbara, Shiro
Koyama, Taiji
Fujishima, Yoshimi
Imamura, Yoshinori
Funakoshi, Yohei
Kiyota, Naomi
Toyama, Hirochika
Kodama, Yuzo
Minami, Hironobu
Article History
Received: 28 July 2020
Accepted: 7 October 2020
First Online: 24 October 2020
Compliance with ethical standards
:
: Masanori Toyoda has received a honoraria from Taiho Pharmaceutical Co., Ltd. Hironaga Satake has received a research grant from Taiho Pharmaceutical Co., Ltd, a honoraria from Eli Lilly Japan Co., Ltd. and Taiho Pharmaceutical Co., Ltd. Hisateru Yasui has received a honoraria from Eli Lilly Japan Co., Ltd. and Taiho Pharmaceutical Co., Ltd. Hironobu Minami has received a research grant and personal fees from Eli Lilly Japan Co., Ltd. and Taiho Pharmaceutical Co., Ltd. The remaining authors have no conflict of interest to declare.
: This study was conducted in compliance with the ethical principles of the Declaration of Helsinki, the principles of Good Clinical Practice and all applicable regulations. The study protocol was approved by the institutional review board of each participating institution, and written informed consent was obtained from all participants.
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.
: The content of this manuscript has not been published or submitted for publication elsewhere and is not under consideration elsewhere.